ATE512T1 - Neue imidazo(2.1-b)-(1.3.4)-thiadiazole, verfahren zu ihrer herstellung und diese enthaltende arzneimittel. - Google Patents

Neue imidazo(2.1-b)-(1.3.4)-thiadiazole, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.

Info

Publication number
ATE512T1
ATE512T1 AT79101541T AT79101541T ATE512T1 AT E512 T1 ATE512 T1 AT E512T1 AT 79101541 T AT79101541 T AT 79101541T AT 79101541 T AT79101541 T AT 79101541T AT E512 T1 ATE512 T1 AT E512T1
Authority
AT
Austria
Prior art keywords
thiadiazols
preparation
pharmaceuticals containing
new imidazo
compounds
Prior art date
Application number
AT79101541T
Other languages
English (en)
Inventor
Harald Dr. Horstmann
Karl-August Dr. Meng
Friedel Dr. Seuter
Eike Dr. Moeller
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Application granted granted Critical
Publication of ATE512T1 publication Critical patent/ATE512T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • C07D285/125—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • C07D285/135—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/84—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Lubricants (AREA)
  • Detergent Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT79101541T 1978-05-31 1979-05-21 Neue imidazo(2.1-b)-(1.3.4)-thiadiazole, verfahren zu ihrer herstellung und diese enthaltende arzneimittel. ATE512T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19782823686 DE2823686A1 (de) 1978-05-31 1978-05-31 Imidazo eckige klammer auf 2.1-b eckige klammer zu eckige klammer auf 1.3.4 eckige klammer zu -thiadiazole
EP79101541A EP0005783B1 (de) 1978-05-31 1979-05-21 Neue Imidazo(2.1-b)-(1.3.4)-thiadiazole, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
ATE512T1 true ATE512T1 (de) 1982-01-15

Family

ID=6040588

Family Applications (1)

Application Number Title Priority Date Filing Date
AT79101541T ATE512T1 (de) 1978-05-31 1979-05-21 Neue imidazo(2.1-b)-(1.3.4)-thiadiazole, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.

Country Status (12)

Country Link
US (1) US4265898A (de)
EP (1) EP0005783B1 (de)
JP (1) JPS54157564A (de)
AT (1) ATE512T1 (de)
AU (1) AU523229B2 (de)
CA (1) CA1128941A (de)
DE (2) DE2823686A1 (de)
DK (1) DK225579A (de)
ES (1) ES481155A1 (de)
FI (1) FI66390C (de)
HU (1) HU179411B (de)
IL (1) IL57420A (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO811630L (no) * 1980-05-29 1981-11-30 Bayer Ag Imidazoazolalkensyreamider, nye mellomprodukter for deres fremstilling, deres fremstilling og deres anvendelse som legemiddel
IT8148047A0 (it) * 1981-03-18 1981-03-18 Manetti & Roberts Italo Brit Composti organici derivati da 2-ami no-5-(o-solfamidofenil)-1,3,4-tiadiazolo loro applicazione terapeutica e procedimento per la loro preparazione
DE3208437A1 (de) * 1982-03-09 1983-09-15 Bayer Ag, 5090 Leverkusen Imidazothiadiazolalkencarbonsaeureamide, neue zwischenprodukte zu ihrer herstellung, ihre herstellung und ihre verwendung in arzneimitteln
US4968494A (en) * 1987-03-27 1990-11-06 Merck & Co., Inc. Methods and compositions for thrombolytic therapy
US5030644A (en) * 1989-07-31 1991-07-09 Merck & Co., Inc. Imidazole compounds and their use as transglutaminase inhibitors
US5077285A (en) * 1989-07-31 1991-12-31 Merck & Co., Inc. Imidazole compounds and their use as transglutaminase inhibitors
US5047416A (en) * 1989-07-31 1991-09-10 Merck & Co., Inc. Triazole compounds and their use as transglutaminase inhibitors
US5019572A (en) * 1990-02-07 1991-05-28 Merck & Co., Inc. Imidazole compounds and their use as transglutaminase inhibitors
US4968713A (en) * 1989-07-31 1990-11-06 Merck & Co., Inc. Certain imidazole compounds as transglutaminase inhibitors
US5021440A (en) * 1989-07-31 1991-06-04 Merck & Co., Inc. Imidazole compounds and their use as transglutaminase inhibitors
US8173661B2 (en) 2006-11-08 2012-05-08 The Rockefeller University Alpha-IIB-beta-3 inhibitors and uses thereof
EP2593106A4 (de) 2010-07-16 2014-01-01 Univ Rockefeller Organische verbindungen
DK2804610T3 (en) 2012-01-16 2019-02-25 Univ Rockefeller ORGANIC COMPOUNDS
CN104640869B (zh) * 2012-04-26 2017-12-12 百时美施贵宝公司 作为用于治疗血小板聚集的蛋白酶激活受体4(par4)抑制剂的咪唑并噻二唑和咪唑并哒嗪衍生物
MX2014012454A (es) * 2012-04-26 2015-03-13 Bristol Myers Squibb Co Derivados de imidazotiadiazol como inhibidores del receptor 4 activado de proteasa (par4) para el tratamiento de agregacion plaquetaria.
HUE048654T2 (hu) * 2012-04-26 2020-08-28 Bristol Myers Squibb Co Imidazotiadiazol és imidazopirazin származékok mint proteázaktivált receptor 4 (PAR4) inhibitorok trombocitaaggregáció kezelésére
EP2682395A1 (de) * 2012-07-04 2014-01-08 Laboratorios Del. Dr. Esteve, S.A. Imidazo[1,2-b]thiazol-Derivate, deren Herstellung und Verwendung als Arzneimittel
US9617279B1 (en) 2014-06-24 2017-04-11 Bristol-Myers Squibb Company Imidazooxadiazole compounds
US9598419B1 (en) 2014-06-24 2017-03-21 Universite De Montreal Imidazotriazine and imidazodiazine compounds
WO2017184520A1 (en) * 2016-04-18 2017-10-26 Vanderbilt University Substituted and fused 6-membered protease activated receptor 4 (par-4) antagonists
WO2019218956A1 (zh) * 2018-05-16 2019-11-21 深圳信立泰药业股份有限公司 作为用于治疗血小板聚集的蛋白酶激活受体4(par4)抑制剂的化合物
WO2019218957A1 (zh) * 2018-05-16 2019-11-21 深圳信立泰药业股份有限公司 作为用于治疗血小板聚集的蛋白酶激活受体4(par4)抑制剂的化合物
US11684622B2 (en) 2018-06-19 2023-06-27 Celecor Therapeutics, Inc. Deuterated RUC-4
CN117203211A (zh) * 2021-11-29 2023-12-08 中国海洋大学 咪唑并噻唑衍生物及其制备方法与应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3726891A (en) * 1970-12-02 1973-04-10 Shell Oil Co Fused 1,2,4-thiadiazolines
US3804823A (en) * 1972-02-15 1974-04-16 Eastman Kodak Co Heterocyclic containing monoazo compounds
GB1464259A (en) * 1975-10-03 1977-02-09 Pfizer Ltd Imidazo-thiazole and -thiadiazole sulphonamides and their use as therapeutic agents
US4042372A (en) * 1976-11-19 1977-08-16 Eli Lilly And Company Substituted thiadiazolotriazinediones and method of preparation

Also Published As

Publication number Publication date
AU4760679A (en) 1979-12-06
DK225579A (da) 1979-12-01
IL57420A (en) 1983-06-15
EP0005783A1 (de) 1979-12-12
FI791708A (fi) 1979-12-01
US4265898A (en) 1981-05-05
DE2823686A1 (de) 1979-12-06
EP0005783B1 (de) 1981-12-30
FI66390C (fi) 1984-10-10
IL57420A0 (en) 1979-09-30
AU523229B2 (en) 1982-07-15
DE2961667D1 (en) 1982-02-18
CA1128941A (en) 1982-08-03
HU179411B (en) 1982-10-28
FI66390B (fi) 1984-06-29
JPS54157564A (en) 1979-12-12
ES481155A1 (es) 1979-11-16

Similar Documents

Publication Publication Date Title
ATE512T1 (de) Neue imidazo(2.1-b)-(1.3.4)-thiadiazole, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
ATE7697T1 (de) Substituierte pyrazinyl-1,2,4-oxadiazol-5-one, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung.
ATE25246T1 (de) Triphenylimidazolyloxyalkansaeuren und ihre derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
ATE324T1 (de) Hydroxypropyl-triazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
JPS5573662A (en) Novel hydroxyethyllazole compound*its manufacture and its use as medicine
DE2967610D1 (en) Pyrimido (6,1-a) isoquinolin-4-ones, process for their preparation and their application in medicaments; intermediates and their preparation
IL82084A0 (en) 1,4-diazepines,their preparation and pharmaceutical compositions containing them
ATE8891T1 (de) Neue 2-aryl-3,4-diaza-bicyclo(4.n.0)alken-(2)-one-(5 , verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
DE69409337D1 (de) Verzweigte Aminothiazole-Derivate, Verfahren zu ihrer Herstellung und pharmazeutische Zusammenstellungen die sie enthalten
ATE49970T1 (de) Neue pyrrolo-benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
IL64472A0 (en) Pharmaceutical compositions containing tricyclic cytosin derivatives,certain new compounds of this class and their production
DE2961394D1 (en) 1-oxo-1h-pyrimido (6,1-b) benzothiazole derivatives, processes for their preparation and pharmaceutical compositions containing them
PT69999A (de) 1,2,3-triazolcarbonsaureamide verfahren zur herstellung dieser verbindungen sowie diese enthaltende biozide mittel
ATE27157T1 (de) Cycloalkylderivate von benzisoselenazolonen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
EP0004968A3 (en) Norbornene(-ane) derivatives, their use as perfuming agents, perfuming composition containing at least one of these derivatives and process for their preparation
ATE2794T1 (de) 1-n-alkylsisomicin-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
MX9303392A (es) Derivados de imidazo benzoxazin-1-ona substituidos y proceso para su preparacion.
ATE14124T1 (de) Ringfoermige sulfenamide, verfahren zu ihrer herstellung, sie enthaltende arzneimittel und deren herstellung.
ATE24912T1 (de) 7,8,9,10-tetrahydrothieno-(3,2-e)-pyrido-(4,3-b - indole, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
ZA80620B (en) New dextrorotatory basic derivative of 9,10-ethanoanthracene,process for the manufacture thereof,pharmaceutical compositions containing this compound and their use
ZA80619B (en) New laevorotatory basic derivative of 9,10-ethanoanthracene,process for the manufacture thereof,pharmaceutical compositions containing this compound and their use
ATE20350T1 (de) Neue vinyloge carboxamide, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
ATE32514T1 (de) 3-(4'-aminobutylamino)-propylamino-bleomycinderivate, verfahren zur ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee